2022
DOI: 10.3390/md20030215
|View full text |Cite
|
Sign up to set email alerts
|

In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis

Abstract: The world is already facing the devastating effects of the SARS-CoV-2 pandemic. A disseminated mucormycosis epidemic emerged to worsen this situation, causing havoc, especially in India. This research aimed to perform a multitargeted docking study of marine-sponge-origin bioactive compounds against mucormycosis. Information on proven drug targets and marine sponge compounds was obtained via a literature search. A total of seven different targets were selected. Thirty-five compounds were chosen using the PASS o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 83 publications
0
14
0
Order By: Relevance
“…Pokharkar et al [ 39 ] have chosen 35 chemical compounds from marine organisms using the PASS online program, and molecular docking and molecular dynamics simulations were performed to assess the possibility of chosen compounds to be a candidate against mucormycosis, and the following protein as potential drug targets were evaluated: CotH3, mucoricin, lanosterol 14α demethylase, exo-1,3-beta-glucan synthase, Rhizopuspepsin, RdRp (RNA-dependent RNA polymerase), and fungal lipase. According to the results, (+)-curcudiol and (+)-curcuphenol, i.e., phenolic derivatives, proved to be the most promising compounds, which exhibited the widest spectrum of inhibition potential [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…Pokharkar et al [ 39 ] have chosen 35 chemical compounds from marine organisms using the PASS online program, and molecular docking and molecular dynamics simulations were performed to assess the possibility of chosen compounds to be a candidate against mucormycosis, and the following protein as potential drug targets were evaluated: CotH3, mucoricin, lanosterol 14α demethylase, exo-1,3-beta-glucan synthase, Rhizopuspepsin, RdRp (RNA-dependent RNA polymerase), and fungal lipase. According to the results, (+)-curcudiol and (+)-curcuphenol, i.e., phenolic derivatives, proved to be the most promising compounds, which exhibited the widest spectrum of inhibition potential [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…For potential antiviral activity, the activity spectra endpoints consisted of picornavirus, influenza, adenovirus, herpes, cytomegalovirus (CMV) and 3C ‐like protease (Human coronavirus) . In terms of potential antifungal activity, the activity spectra endpoints encompassed Aspergillus nuclease S1, Aspergillopepsin I and II, yeast ribonuclease, antifungal enhancer, Pneumocystis, Lanosterol 14 alpha demethylase, Mucorpepsin, rhizopuspepsin and ADP‐ribosylarginine hydrolase inhibitors [91–92] …”
Section: Methodsmentioning
confidence: 99%
“…In terms of potential antifungal activity, the activity spectra endpoints encompassed Aspergillus nuclease S1, Aspergillopepsin I and II, yeast ribonuclease, antifungal enhancer, Pneumocystis, Lanosterol 14 alpha demethylase, Mucorpepsin, rhizopuspepsinand ADP-ribosylarginine hydrolase inhibitors. [91][92]…”
Section: Pass(prediction Of Activity Spectra For Substances)mentioning
confidence: 99%
“…Molecular Dynamics Simulations. On the base of docking outcomes, we conducted molecular dynamic simulation for the selected docked complexes (having lowest energy values) utilizing IMODS sever (http://imods.chaconlab.org) 43 with the parameters adjusted at default values. 44 IMODS is an open access web server which assists in evaluation of the stability of a complex by investigating its detailed coordinates in NMA (normal-mode analysis).…”
Section: Enzyme Inhibition Activitymentioning
confidence: 99%